Journal of Applied Physiology, Vol 79, Issue 6 1998-2006, Copyright © 1995 by American Physiological Society

ARTICLES

Altered beta-adrenergic and cholinergic pulmonary vascular responses after total cardiopulmonary bypass

M. Friedman, S. Y. Wang, G. L. Stahl, R. G. Johnson and F. W. Sellke
Department of Surgery, Beth Israel Hospital, Boston, Massachusetts 02215, USA.

Cardiopulmonary bypass (CPB) is often followed by pulmonary hypertension, but the effects of extracorporeal circulation on vascular reactivity remain largely unknown. In this study, the influence of total CPB (t-CPB) on beta-adrenergic and cholinergic receptor-mediated pulmonary microvascular responses was examined. Sheep were placed on t-CPB without ventilation. After 90 min, sheep were separated from t-CPB and the lungs were perfused normally for 60 min. Pulmonary artery infusion of acetylcholine (muscarinic cholinergic agonist, ACh) increased pulmonary vascular resistance significantly more and isoproterenol (beta-adrenergic agonist, Iso) decreased pulmonary vascular resistance less after than before t-CPB. The response to sodium nitroprusside (SNP, guanylate cyclase activator) was similar before and after t-CPB. Relaxations (in vitro) of isolated pressurized (20 mmHg) microvessels to Iso and ACh were markedly reduced after t-CPB. Treatment with NPC-15669 (N-[9H-(2,7,-dimethylfluorenyl-9-methoxy)carbonyl]-L-leucine) did not affect these changes in vessel reactivity, although leukocyte sequestration in the lungs was reduced with the drug. The in vitro response to forskolin (adenylate cyclase activator) and SNP was similar before and after t-CPB. Complement-activated serum caused microvessels to contract in response to ACh, but it had no effect on Iso, forskolin, or SNP responses, suggesting that activation of the alternate complement pathway causes a selective reduction in endothelium-dependent relaxation. We conclude that t-CPB impairs cholinergic and beta-adrenergic pulmonary vascular responses due to effects at the level of the transmembrane receptor or coupling to the second messenger systems.

This article has been cited by other articles:

				J. Seeburger, J. Hoffmann, H. P. Wendel, G. Ziemer, and H. Aebert Gene Expression Changes in Leukocytes During Cardiopulmonary Bypass Are Dependent on Circuit Coating Circulation, August 30, 2005; 112(9_suppl): I-224 - I-228. [Abstract] [Full Text] [PDF]

				B. Rozec, S. Serpillon, G. Toumaniantz, C. Seze, Y. Rautureau, O. Baron, J. Noireaud, and C. Gauthier Characterization of Beta3-Adrenoceptors in Human Internal Mammary Artery and Putative Involvement in Coronary Artery Bypass Management J. Am. Coll. Cardiol., July 19, 2005; 46(2): 351 - 359. [Abstract] [Full Text] [PDF]

				M. Ruel, C. Bianchi, T. A. Khan, S. Xu, J. R. Liddicoat, P. Voisine, E. Araujo, H. Lyon, I. S. Kohane, T. A. Libermann, et al. Gene expression profile after cardiopulmonary bypass and cardioplegic arrest J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1521 - 1530. [Abstract] [Full Text] [PDF]

				A. Agah, M. C. Montalto, C. L. Kiesecker, M. Morrissey, M. Grover, K. L. Whoolery, R. P. Rother, and G. L. Stahl Isolation, Characterization, and Cloning of Porcine Complement Component C7 J. Immunol., July 15, 2000; 165(2): 1059 - 1065. [Abstract] [Full Text] [PDF]

				M. Tofukuji, G. L. Stahl, C. Metais, M. Tomita, A. Agah, C. Bianchi, M. P. Fink, and F. W. Sellke Mesenteric dysfunction after cardiopulmonary bypass: role of complement C5a Ann. Thorac. Surg., March 1, 2000; 69(3): 799 - 807. [Abstract] [Full Text] [PDF]

				C. D. Collard, A. Agah, W. Reenstra, J. Buras, and G. L. Stahl Endothelial Nuclear Factor-{kappa}B Translocation and Vascular Cell Adhesion Molecule-1 Induction by Complement : Inhibition With Anti-Human C5 Therapy or cGMP Analogues Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2623 - 2629. [Abstract] [Full Text] [PDF]

				K. W. Park, M. Tofukuji, C. Metais, M. E. Comunale, H. B. Dai, M. Simons, G. L. Stahl, A. Agah, and F. W. Sellke Attenuation of Endothelium-Dependent Dilation of Pig Pulmonary Arterioles After Cardiopulmonary Bypass Is Prevented by Monoclonal Antibody to Complement C5a Anesth. Analg., July 1, 1999; 89(1): 42 - 42. [Abstract] [Full Text] [PDF]

				A. P. Vakeva, A. Agah, S. A. Rollins, L. A. Matis, L. Li, and G. L. Stahl Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion : Role of the Terminal Complement Components and Inhibition by Anti-C5 Therapy Circulation, June 9, 1998; 97(22): 2259 - 2267. [Abstract] [Full Text] [PDF]

				A. Stamler, S. Y. Wang, D. E. Aguirre, R. G. Johnson, and F. W. Sellke Cardiopulmonary Bypass Alters Vasomotor Regulation of the Skeletal Muscle Microcirculation Ann. Thorac. Surg., August 1, 1997; 64(2): 460 - 465. [Abstract] [Full Text]

				A. Stamler, S. Y. Wang, J. Li, R. L. Thurer, F. J. Schoen, and F. W. Sellke Moderate Hypothermia Reduces Cardiopulmonary Bypass-Induced Impairment of Cerebrovascular Responses to Platelet Products Ann. Thorac. Surg., July 1, 1996; 62(1): 191 - 198. [Abstract] [Full Text]